Mostafa Ejtehadifar
1, Karim Shamsasenjan
1,2*, Aliakbar Movassaghpour
1, Parvin Akbarzadehlaleh
3, Nima Dehdilani
1, Parvaneh Abbasi
1, Zahra Molaeipour
1, Mahshid Saleh
11 Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
2 Iran Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tabriz, Iran.
3 Drug Applied Research Center and Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract
Although
physiological and pathological role of hypoxia have been appreciated in
mammalians for decades however the cellular biology of hypoxia more clarified
in the past 20 years. Discovery of the transcription factor hypoxia-inducible
factor (HIF)-1, in the 1990s opened a new window to investigate the mechanisms
behind hypoxia. In different cellular contexts HIF-1 activation show variable
results by impacting various aspects of cell biology such as cell cycle,
apoptosis, differentiation and etc. Mesenchymal stem cells (MSC) are unique
cells which take important role in tissue regeneration. They are characterized
by self-renewal capacity, multilineage potential, and immunosuppressive
property. Like so many kind of cells, hypoxia induces different responses in
MSCs by HIF-1 activation. The activation of this molecule changes the growth,
multiplication, differentiation and gene expression profile of MSCs in their
niche by a complex of signals. This article briefly discusses the most
important effects of hypoxia in growth kinetics, signalling pathways, cytokine
secretion profile and expression of chemokine receptors in different
conditions.